FORA Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,623
| Closed | -$422K | – | 388 |
|
|
2024
Q3 | $422K | Buy |
+14,623
| New | +$422K | 0.05% | 318 |
|
|
2023
Q3 | – | Sell |
-31,203
| Closed | -$2.84M | – | 450 |
|
|
2023
Q2 | $2.84M | Buy |
31,203
+23,292
| +294% | +$2.12M | 0.4% | 70 |
|
|
2023
Q1 | $522K | Buy |
+7,911
| New | +$522K | 0.05% | 346 |
|
|
2022
Q2 | – | Sell |
-14,009
| Closed | -$693K | – | 422 |
|
|
2022
Q1 | $693K | Buy |
+14,009
| New | +$693K | 0.12% | 223 |
|
|
2021
Q2 | – | Sell |
-1,378
| Closed | -$59K | – | 864 |
|
|
2021
Q1 | $59K | Buy |
+1,378
| New | +$59K | 0.02% | 517 |
|
|
2020
Q1 | – | Sell |
-2,156
| Closed | -$66K | – | 1024 |
|
|
2019
Q4 | $66K | Buy |
+2,156
| New | +$66K | 0.01% | 847 |
|